Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Radioiodine Treatment”

70 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 70 results

Large-scale testing (Phase 3)Study completedNCT00295763
What this trial is testing

A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.

Who this might be right for
Differentiated Thyroid Cancer
Genzyme, a Sanofi Company 61
Not applicableActive Not RecruitingNCT03624751
What this trial is testing

Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment

Who this might be right for
Thyroid Cancer
Taichung Veterans General Hospital 300
Not applicableUnknownNCT02114619
What this trial is testing

Comparative Study of Different I-131 Doses in Graves' Disease

Who this might be right for
Graves' Disease
Mashhad University of Medical Sciences 450
Early research (Phase 1)Ended earlyNCT03469011
What this trial is testing

Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.

Who this might be right for
Papillary Thyroid Cancer
AHS Cancer Control Alberta 14
Early research (Phase 1)Study completedNCT01413113
What this trial is testing

Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery

Who this might be right for
Recurrent Thyroid CancerStage IVA Follicular Thyroid CancerStage IVA Papillary Thyroid Cancer+4 more
University of Washington 6
Large-scale testing (Phase 3)UnknownNCT04776993
What this trial is testing

A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' Orbitopathy

Who this might be right for
Graves' Orbitopathy
University of Pisa 52
Not applicableNot Yet RecruitingNCT07405320
What this trial is testing

A Brief Video Intervention to Improve Patient Outcomes Following Radioiodine Treatment

Who this might be right for
Thyroid CancerHyperthyroidismRadioiodine Treatment
University of Auckland, New Zealand 80
Not applicableStudy completedNCT03363347
What this trial is testing

BRAF V600E and Redifferentiation Therapy in Radioiodine-refractory Papillary Thyroid Cancer

Who this might be right for
Thyroid Cancer
Heidelberg University 25
Testing effectiveness (Phase 2)Study completedNCT00251316
What this trial is testing

Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer

Who this might be right for
Thyroid CancerDifferentiated Thyroid Carcinoma
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 34
Testing effectiveness (Phase 2)Study completedNCT00454220
What this trial is testing

Study to Determine the Dose, the Safety and Effectiveness of a New Drug, Modified Release rhTSH, in Patients With Multinodular Goiter

Who this might be right for
Multinodular Goiter
Genzyme, a Sanofi Company 96
Not applicableUnknownNCT06062563
What this trial is testing

Study of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid Cancer

Who this might be right for
Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
Peking Union Medical College Hospital 10
Not applicableApproved For MarketingNCT02211222
What this trial is testing

An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer
Eisai Inc.
Testing effectiveness (Phase 2)UnknownNCT03732495
What this trial is testing

Study of the Efficacy of Lenvatinib Combined With Denosumab in the Treatment of Patients With Predominant Bone Metastatic Radioiodine Refractory Differentiated Thyroid Carcinomas

Who this might be right for
Thyroid Cancer Metastatic
Centre Leon Berard 35
Not applicableUnknownNCT00151723
What this trial is testing

Does Radioiodine Treatment Prevent Atrial Fibrillation and Bone Loss in Endogenous Subclinical Hyperthyroidism?

Who this might be right for
Hyperthyroidism
Radboud University Medical Center 200
Not applicableStudy completedNCT03397238
What this trial is testing

Myeloid Cell Reprogramming in Thyroid Carcinoma

Who this might be right for
Thyroid Cancer
Radboud University Medical Center 41
Not applicableStudy completedNCT01945125
What this trial is testing

Effects of THW and rhTSH in Glomerular Filtration Rate During RIT

Who this might be right for
Other Impaired Renal Function Disorder
University of Sao Paulo General Hospital 28
Not applicableUnknownNCT04391244
What this trial is testing

Investigating National Solutions for Personalised Iodine-131 Radiation Exposure

Who this might be right for
Differentiated Thyroid Cancer
Royal Marsden NHS Foundation Trust 150
Not applicableStudy completedNCT02375451
What this trial is testing

Effect of Childhood Radioiodine Therapy on Salivary Function

Who this might be right for
XerostomiaHyperthyroidismThyroid Cancer
Boston Children's Hospital 70
Large-scale testing (Phase 3)Active Not RecruitingNCT03690388
What this trial is testing

Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy

Who this might be right for
Differentiated Thyroid Cancer
Exelixis 187
Large-scale testing (Phase 3)Looking for participantsNCT04290663
What this trial is testing

Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up

Who this might be right for
Thyroid CancerIntermediate Risk
Centre Francois Baclesse 476
Load More Results